Garri Zmudze
Managing Partner at LongeVC, Advising the pioneers of next-gen medicine, breakthrough biotech and accessible longevity
Garri is a seasoned business angel with an extensive track record in tech business and an early investor in science-intensive ventures, such as Insilico Medicine and Basepaws. Prior to founding LongeVC, he co-founded Longenesis — a medical technology startup company working towards providing a technological bridge between Healthcare institutions and the BioTech industry with an aim to help identify and unlock the hidden value of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those in need. In 2021, Garri became the Executive Coordinator of Longevity Science Foundation — a Swiss non-profit organisation advancing human longevity by funding research and development of medical technologies to extend the healthy human lifespan to more than 120 years.
Visit website: https://garrizmudze.com/
See also: LongeVC - Company supporting early-stage biotech and longevity-focused founders
Details last updated 13-Nov-2021
Garri Zmudze is also referenced in the following:
ARDD 2023 - 10th Aging Research & Drug Discovery Meeting
28-Aug-2023 to 01-Sep-2023
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
Innovations in Consumer Longevity Data: A Global Perspective
19-Nov-2021
Ageing Research at King's (ARK) Longevity Week 2021 Event (FREE)